An NF-kB/TNF-alpha signalling feedback loop acts to coordinate tissue regeneration and macrophage behaviour in zebrafish
Inflammatory cells are crucial regulators of infection and regeneration that actively migrate to affected tissues. NF-kB and TNF-alpha (TNFα) are master regulators of immune signalling, but their importance for immune cell migration is much less well understood. We have therefore investigated how NF-kB and TNFα regulate both macrophage function and behaviour in vivo using a zebrafish model of tissue repair. We show that NF-kB activity differentially regulates TNFα activity through Tnf receptors 1a and 1b to control macrophage responses to injury. Loss of NF-kB in macrophages results in elevated TNFα expression and results in more directional migration. Impaired NF-kB activity in macrophages perturbs tissue regeneration, causes increased proliferation, altered pro- and anti-inflammatory gene expression and delays fin regeneration. We identify a crucial role for NF-kB modulation of TNFα signaling to regulate macrophage responses to tissue injury, which are necessary for effective fin regeneration.
Authors
- Elisabeth M. Busch‐Nentwich (ORCID: https://orcid.org/0000-0001-6450-744X)
- Rob Knight (ORCID: https://orcid.org/0000-0002-0975-9019)
- Yue Yuan (ORCID: https://orcid.org/0000-0002-6698-3009)
- Antonia Pia Cumine
- Carlene Dyer (ORCID: https://orcid.org/0000-0002-2136-8504)
- Isabel Bravo (ORCID: https://orcid.org/0000-0001-7615-6392)
- Yi Feng (ORCID: https://orcid.org/0000-0001-8021-7776)
- Kalliopi Arkoudi
Institutions
- Guy's Hospital (GB)
- Carl Zeiss (Germany) (DE)
- Queen Mary University of London (GB)
- King's College London (GB)
- Edinburgh Cancer Research (GB)
- William Harvey Research Institute (GB)
- Centre for Inflammation Research (GB)
- University of Edinburgh (GB)
Publication Details
- Journal
- npj Regenerative Medicine
- Published
- 2025-06-03
- DOI
- https://doi.org/10.1038/s41536-025-00414-1
- Citations
- 9
- Primary Topic
- Immune cells in cancer
- Type
- article
- Field-Weighted Citation Impact
- 7.18
Funders
- Wellcome Trust
- Cancer Research UK
- Biotechnology and Biological Sciences Research Council